| I-016 Giammarco Baiardi population pharmacokinetics and dose rationale for deferasirox in the treatment of iron overload in paediatric patients undergoing hematopoietic stem cell transplantation Wednesday 10:20-11:50 |
| I-016 Giammarco Baiardi population pharmacokinetics and dose rationale for deferasirox in the treatment of iron overload in paediatric patients undergoing hematopoietic stem cell transplantation Wednesday 10:20-11:50 |